Literature DB >> 11429229

Extent and kinetics of recovery of occult spinal cord injury.

K K Ang1, G L Jiang, Y Feng, L C Stephens, S L Tucker, R E Price.   

Abstract

PURPOSE: To obtain clinically useful quantitative data on the extent and kinetics of recovery of occult radiation injury in primate spinal cord, after a commonly administered elective radiation dose of 44 Gy, given in about 2 Gy per fraction. METHODS AND MATERIALS: A group of 56 rhesus monkeys was assigned to receive two radiation courses to the cervical and upper thoracic spinal cord, given in 2.2 Gy per fraction. The dose of the initial course was 44 Gy in all monkeys. Reirradiation dose was 57.2 Gy, given after 1-year (n = 16) or 2-year (n = 20) intervals, or 66 Gy, given after 2-year (n = 4) or 3-year (n = 14) intervals. Two animals developed intramedullary tumors before reirradiation and, therefore, did not receive a second course. The study endpoint was myeloparesis, manifesting predominantly as lower extremity weakness and decrease in balance, occurring within 2.5 years after reirradiation, complemented by histologic examination of the spinal cord. The data obtained were analyzed along with data from a previous study addressing single-course tolerance, and data from a preliminary study of reirradiation tolerance.
RESULTS: Only 4 of 45 monkeys completing the required observation period (2-2.5 years after reirradiation, 3-5.5 years total) developed myeloparesis. The data revealed a substantial recovery of occult injury induced by 44 Gy within the first year, and suggested additional recovery between 1 and 3 years. Fitting the data with a model, assuming that all (single course and reirradiation) dose-response curves were parallel, yielded recovery estimates of 33.6 Gy (76%), 37.6 Gy (85%), and 44.6 Gy (101%) of the initial dose, after 1, 2, and 3 years, respectively, at the 5% incidence (D(5)) level. The most conservative estimate, using a model in which it was assumed that there was no recovery between 1 and 3 years following initial irradiation and that the combined reirradiation curve was not necessarily parallel to the single-course curve, still showed an overall recovery equivalent to 26.8 Gy (61%). The spinal cords of symptomatic monkeys consistently revealed a mixture of white matter necrosis and vascular injury, but the majority of spinal cords of asymptomatic animals did not exhibit overt lesions detectable by light microscopy.
CONCLUSION: Combined analysis with the data of the previous studies yielded firm evidence that the spinal cord has a large capacity to recover from occult radiation injury induced by a commonly prescribed elective dose. This finding strengthens the rationale for selective use of radiotherapy to treat second primary tumors arising in previously irradiated tissues or late recurrences. However, some caution should be exercised in applying quantitative experimental data, because the length of follow-up in these experiments was limited to 2-2.5 years after reirradiation, whereas human myelopathy cases occasionally occur after longer latency. Because there is a large variation in long-term recovery among tissues, the tolerance of other tissues at risk should also be taken into account in prescribing therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11429229     DOI: 10.1016/s0360-3016(01)01599-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  36 in total

Review 1.  The impact on oncology of the interaction of radiation therapy and radiobiology.

Authors:  Vicente Pedraza Muriel
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

Review 2.  Spinal cord tolerance in the age of spinal radiosurgery: lessons from preclinical studies.

Authors:  Paul M Medin; Thomas P Boike
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-22       Impact factor: 7.038

3.  Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial.

Authors:  L Vormittag; C Lemaire; D Radonjic; G Kornek; E Selzer
Journal:  Strahlenther Onkol       Date:  2012-02-10       Impact factor: 3.621

Review 4.  Chordoma in children: Case-report and review of literature.

Authors:  Jean-Louis Habrand; Jean Datchary; Stéphanie Bolle; Anne Beaudré; Ludovic de Marzi; Kévin Beccaria; Dinu Stefan; Jacques Grill; Rémi Dendale
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-08

5.  Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.

Authors:  Victor H F Lee; Dora L W Kwong; To-Wai Leung; Sherry C Y Ng; Ka-On Lam; Chi-Chung Tong; Chun-Kin Sze
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-13       Impact factor: 2.503

6.  Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors.

Authors:  Shuai Liu; Taixiang Lu; Chong Zhao; Jingxian Shen; Yunming Tian; Ying Guan; Lei Zeng; Weiwei Xiao; Shaomin Huang; Fei Han
Journal:  J Neurooncol       Date:  2014-07-02       Impact factor: 4.130

7.  Initial experience of hypofractionated radiation retreatment with true beam and flattening filter free beam in selected case reports of recurrent nasopharyngeal carcinoma.

Authors:  Filippo Alongi; Elena Clerici; Sara Pentimalli; Pietro Mancosu; Marta Scorsetti
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-10

8.  Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations.

Authors:  Carsten Nieder; Laurie E Gaspar; Dirk De Ruysscher; Matthias Guckenberger; Minesh P Mehta; Chad G Rusthoven; Arjun Sahgal; Eleni Gkika
Journal:  Strahlenther Onkol       Date:  2018-01-23       Impact factor: 3.621

9.  The value of image-guided intensity-modulated radiotherapy in challenging clinical settings.

Authors:  S J Treece; M Mukesh; Y L Rimmer; S J Tudor; J C Dean; R J Benson; D L Gregory; G Horan; S J Jefferies; S G Russell; M V Williams; C B Wilson; N G Burnet
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

10.  Aortic dose constraints when reirradiating thoracic tumors.

Authors:  Jaden D Evans; Daniel R Gomez; Arya Amini; Neal Rebueno; Pamela K Allen; Mary K Martel; Justin M Rineer; Kie Kian Ang; Sarah McAvoy; James D Cox; Ritsuko Komaki; James W Welsh
Journal:  Radiother Oncol       Date:  2013-02-28       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.